Professional IVD Manufacturer


Supply high sensitivity and specificity
Quality diagnostics reagents at reasonable price

 

About Biocare Diagnostics Limited
History

1997.3.8     TDL built by Biochemistry and Investors in Zhuhai
2000.9         Launch rapid test production line
2001.3         Sucessful developed rotavirus and adenovirus stool antigen rapid tests
2003.5         Launch FABP rapid test
2003.11       Export Rotavirus and Adenovirus Stick to USA and EU
2004.6         Launch Rota/adeno Combi rapid test to the market
2007.5         Change company name to Biocare Diagnostics Ltd
2008.7         Move to present address
2009. 10      

Biocare Diagnostics Ltd is a in vitro diagnostics reagents manufacturer including lateral flow rapid tests, immunoassay kits, cell and microbiological stains We also supply part raw materials for ELISA and lateral flow tests that made by us.

The R&D team work for over 5 years, they developed a new patent lateral flow technology, it improve the sensitivity and specificity, and make the tests have clear backgroud, longer shelf life and lower Turn Around Time than tradional technology,it also save raw materials, that make us can provide quality products to customers at reasonable price.

Biocare also provide OEM opputunities for Rotavirus, Adenovirus, Rota/adeno, Strep A, Hemoglobin, Troponin I lateral flow tests and HBsAg, HCV, HIV ELISA kits to other IVD kits manufacturers.

Rota/adeno Dipstick

Rota-Adeno is a rapid, qualitative, chromatographic immunoassay which simultaneously detects rotaviruses and adenoviruses in stool samples.Rotaviruses and adenoviruses are responsible for the majority of pediatric diarrhea cases. Rapid diagnosis of viral diarrhea enables:

Immediate administration of appropriate therapy;

Rapid isolation of infected patients or carriers in order to limit outbreaks;

Significant decrease of cases of diarrhea of unknown origin

More details.....

RSV Rapid Test

 The RSV test is intended for the rapid, qualitative detection of respiratory syncytial virus (RSV) directly from nasopharyngeal swab, and nasal aspirate specimens in children less than 6 years and adults over the age of 60. RSV is the major cause of serious lower respiratory disease, including bronchiolitis and pneumonia.

HBsAg Cassettte
The discovery of Australia antigen and subsequent identification as the surface antigen of Hepatitis B virus (HBsAg) represents a significant breakthrough in the understanding of the disease. Screening of blood donors for the presence of this antigen in serum has significantly reduced the incidence of Hepatitis B in blood transfusion recipients. Furthermore, anti-HBsAg determination can be used to: a) monitor the progress of patients recovering from Hepatitis B viral infection; b) indicate if the patient has had prior immunological exposure to HBsAg; and c) study the epidemiological factors associated with transmission of HBsAg.